.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Diazepam - Generic Drug Details

« Back to Dashboard
Diazepam is the generic ingredient in eight branded drugs marketed by Martec Usa Llc, Sandoz, Ferndale Labs, Actavis Elizabeth, Ivax Sub Teva Pharms, Eurohlth Intl Sarl, Warner Chilcott, Watson Labs, Roxane, Parenta Pharms, Quantum Pharmics, Us Army, Mylan, Dava Pharms Inc, Lannett Holdings Inc, Mayne Pharma, Valeant Pharms North, Vintage Pharms, Barr, Teva Pharms, Halsey, Abraxis Pharm, Par Pharm, Roche, Watson Labs Inc, Marsam Pharms Llc, Pioneer Pharms, Hospira, Pharmacia And Upjohn, and Duramed Pharms Barr, and is included in eighty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for diazepam. Forty-eight suppliers are listed for this compound.

Summary for Generic Name: diazepam

Tradenames:8
Patents:0
Applicants:30
NDAs:82
Drug Master File Entries: see list8
Suppliers / Packaging: see list48
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: diazepam

Clinical Trials for: diazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
DIAZEPAM
diazepam
TABLET;ORAL070463-001Feb 25, 1986DISCNNo
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL072431-001Apr 29, 1988DISCNNo
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-002Jul 29, 1997DISCNNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: diazepam

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-001Jul 29, 19975,462,740<disabled>
Pharmacia And Upjohn
DIZAC
diazepam
INJECTABLE;INJECTION019287-001Jun 18, 1993RE32393<disabled>
Roche
VALIUM
diazepam
TABLET;ORAL013263-002Approved Prior to Jan 1, 19824,316,897<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc